Pathology

Utilization of 3D Fluorescent Imaging in Multi-modality Studies

3D Tissue Imaging to Characterize Gene Therapies in Preclinical Drug Discovery

In Vivo and Tissue Molecular Imaging in Gene Therapy

Clinical

Molecular Imaging in Neurodegenerative Disorders: Developing a Translational Toolbox

Wherefore art Tau? Developing Methods for the Qualitative Interpretation of Tau PET

The IQ Analytics Platform: Amyloid-IQ, Tau-IQ, and Dat-IQ

What Can We Learn From Primary Age-Related Tauopathy (PART)

Applications of Machine Learning in Medical Image Analysis

Advanced Imaging Biomarkers in Alzheimer's Disease

Image Acquisition is Easy; Constructing Data Analysis Workflows that Work for you is the Challenging and Critical Part

Obtaining High Quality Imaging Data from Clinical Trials

What’s New in iPACS and VivoQuant With an Eye on the Future

Translational Aspects of Intrathecal Drug Administration

Machine Learning & Deep Learning for Image Processing Applications

Imaging Biomarkers for Measuring Pharmacodynamic Effects of CNS Drugs

How MRI is Helping to De-risk Drug Development

In Vivo and Tissue Molecular Imaging in Gene Therapy

Molecular & Functional Imaging in Early Phase Drug Development

AmyloidIQ – An algorithm to increase power in clinical trials and automate radiological reads

Preclinical

CNS Probe Development, Validation and Utility in Drug R&D. What Have We Learnt From Small Molecules to Antibodies?

Development of Novel PET Radioligands for PET Imaging Applications 

Utilization of 3D Fluorescent Imaging in Multi-modality Studies

What’s New in iPACS and VivoQuant With an Eye on the Future

Image Acquisition is Easy; Constructing Data Analysis Workflows that Work for you is the Challenging and Critical Part

Applications of Machine Learning in Medical Image Analysis

3D Tissue Imaging to Characterize Gene Therapies in Preclinical Drug Discovery

Translational Aspects of Intrathecal Drug Administration

Machine Learning & Deep Learning for Image Processing Applications

How MRI is Helping to De-risk Drug Development

In Vivo and Tissue Molecular Imaging in Gene Therapy